Compare Xylem, Inc. (XYL) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Xylem, Inc. vs Zimmer Biomet Holdings Inc — how do they compare? Xylem, Inc. trades at $117.66 (market cap $28.67B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Xylem, Inc. is the larger of the two by market cap, and Xylem, Inc. pays the higher dividend (1.43%). Which is the better fit depends on your goals.
| XYL | ZBH | |
|---|---|---|
Market Cap | $28.67B | $17.36B |
Sector | Industrials | Health |
52-Week High | $152.95 | $107.71 |
52-Week Low | $106.34 | $79.58 |
Enterprise Value | $29.92B | $24.40B |
Dividend Yield | 1.43% | 1.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Xylem, Inc.
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
